Bank of America Corp DE Purchases 86,075 Shares of ASP Isotopes Inc. (NASDAQ:ASPI)

Bank of America Corp DE grew its position in shares of ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) by 318.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 113,084 shares of the company's stock after acquiring an additional 86,075 shares during the period. Bank of America Corp DE owned about 0.16% of ASP Isotopes worth $512,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. JPMorgan Chase & Co. boosted its position in shares of ASP Isotopes by 854.6% during the fourth quarter. JPMorgan Chase & Co. now owns 211,893 shares of the company's stock valued at $960,000 after purchasing an additional 189,697 shares in the last quarter. BNP Paribas Financial Markets bought a new position in ASP Isotopes in the fourth quarter worth $34,000. Price T Rowe Associates Inc. MD lifted its position in ASP Isotopes by 14.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 21,646 shares of the company's stock valued at $99,000 after buying an additional 2,757 shares during the period. Avantax Advisory Services Inc. purchased a new position in ASP Isotopes during the fourth quarter valued at $45,000. Finally, Northern Trust Corp boosted its holdings in shares of ASP Isotopes by 15.5% during the 4th quarter. Northern Trust Corp now owns 435,688 shares of the company's stock valued at $1,974,000 after buying an additional 58,525 shares in the last quarter. Hedge funds and other institutional investors own 16.80% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group upped their target price on shares of ASP Isotopes from $8.50 to $11.00 and gave the stock a "buy" rating in a research report on Wednesday, May 21st.

ASP Isotopes Stock Down 1.7%

Shares of NASDAQ ASPI traded down $0.15 on Thursday, reaching $8.65. 482,988 shares of the company's stock traded hands, compared to its average volume of 2,725,872. The business's 50 day simple moving average is $6.57 and its two-hundred day simple moving average is $5.52. ASP Isotopes Inc. has a 12 month low of $1.86 and a 12 month high of $10.08. The company has a market cap of $725.52 million, a price-to-earnings ratio of -14.18 and a beta of 3.56. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80.

Insider Buying and Selling

In other news, CEO Paul Elliot Mann sold 316,666 shares of ASP Isotopes stock in a transaction dated Thursday, April 17th. The stock was sold at an average price of $5.62, for a total value of $1,779,662.92. Following the completion of the transaction, the chief executive officer now owns 7,315,454 shares of the company's stock, valued at $41,112,851.48. The trade was a 4.15% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Robert Ainscow sold 66,668 shares of the company's stock in a transaction dated Thursday, April 17th. The stock was sold at an average price of $5.62, for a total transaction of $374,674.16. Following the completion of the transaction, the chief operating officer now owns 1,419,992 shares in the company, valued at approximately $7,980,355.04. The trade was a 4.48% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 766,667 shares of company stock worth $4,358,502 in the last 90 days. Insiders own 21.40% of the company's stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.